| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.059 | 0.3 |